<VariationArchive VariationID="457327" VariationName="NM_001370259.2(MEN1):c.563_564del (p.Pro188fs)" VariationType="Deletion" Accession="VCV000457327" Version="10" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2017-12-26" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="461847" VariationID="457327">
      <GeneList>
        <Gene Symbol="MEN1" FullName="menin 1" GeneID="4221" HGNC_ID="HGNC:7010" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64803516" stop="64811294" display_start="64803516" display_stop="64811294" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64570985" stop="64578765" display_start="64570985" display_stop="64578765" Strand="-" />
          </Location>
          <OMIM>613733</OMIM>
          <Haploinsufficiency last_evaluated="2022-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001370259.2(MEN1):c.563_564del (p.Pro188fs)</Name>
      <CanonicalSPDI>NC_000011.10:64807980:GGG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64807981" stop="64807982" display_start="64807981" display_stop="64807982" variantLength="2" positionVCF="64807980" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64575453" stop="64575454" display_start="64575453" display_stop="64575454" variantLength="2" positionVCF="64575452" referenceAlleleVCF="TGG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P188fs</ProteinChange>
      <ProteinChange>P193fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130799.2" sequenceAccession="NM_130799" sequenceVersion="2" change="c.563_564delCC">
            <Expression>NM_130799.2:c.563_564delCC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.64807982_64807983del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.64807982_64807983del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.64575454_64575455del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.64575454_64575455del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008929.1" sequenceAccession="NG_008929" sequenceVersion="1" change="g.8313_8314del">
            <Expression>NG_008929.1:g.8313_8314del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033040.1" sequenceAccession="NG_033040" sequenceVersion="1" change="g.260_261del">
            <Expression>NG_033040.1:g.260_261del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000244.4" sequenceAccession="NM_000244" sequenceVersion="4" change="c.578_579del">
            <Expression>NM_000244.4:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000235.3" sequenceAccession="NP_000235" sequenceVersion="3" change="p.Pro193fs">
            <Expression>NP_000235.3:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370251.2" sequenceAccession="NM_001370251" sequenceVersion="2" change="c.563_564del">
            <Expression>NM_001370251.2:c.563_564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357180.2" sequenceAccession="NP_001357180" sequenceVersion="2" change="p.Pro188fs">
            <Expression>NP_001357180.2:p.Pro188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370259.2" sequenceAccession="NM_001370259" sequenceVersion="2" change="c.563_564del" MANESelect="true">
            <Expression>NM_001370259.2:c.563_564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357188.2" sequenceAccession="NP_001357188" sequenceVersion="2" change="p.Pro188fs">
            <Expression>NP_001357188.2:p.Pro188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370260.2" sequenceAccession="NM_001370260" sequenceVersion="2" change="c.563_564del">
            <Expression>NM_001370260.2:c.563_564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357189.2" sequenceAccession="NP_001357189" sequenceVersion="2" change="p.Pro188fs">
            <Expression>NP_001357189.2:p.Pro188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370261.2" sequenceAccession="NM_001370261" sequenceVersion="2" change="c.563_564del">
            <Expression>NM_001370261.2:c.563_564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357190.2" sequenceAccession="NP_001357190" sequenceVersion="2" change="p.Pro188fs">
            <Expression>NP_001357190.2:p.Pro188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130799.3" sequenceAccession="NM_130799" sequenceVersion="3" change="c.563_564del">
            <Expression>NM_130799.3:c.563_564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570711.2" sequenceAccession="NP_570711" sequenceVersion="2" change="p.Pro188fs">
            <Expression>NP_570711.2:p.Pro188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130800.3" sequenceAccession="NM_130800" sequenceVersion="3" change="c.578_579del">
            <Expression>NM_130800.3:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570712.2" sequenceAccession="NP_570712" sequenceVersion="2" change="p.Pro193fs">
            <Expression>NP_570712.2:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130801.3" sequenceAccession="NM_130801" sequenceVersion="3" change="c.578_579del">
            <Expression>NM_130801.3:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570713.2" sequenceAccession="NP_570713" sequenceVersion="2" change="p.Pro193fs">
            <Expression>NP_570713.2:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130802.3" sequenceAccession="NM_130802" sequenceVersion="3" change="c.578_579del">
            <Expression>NM_130802.3:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570714.2" sequenceAccession="NP_570714" sequenceVersion="2" change="p.Pro193fs">
            <Expression>NP_570714.2:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130803.3" sequenceAccession="NM_130803" sequenceVersion="3" change="c.578_579del">
            <Expression>NM_130803.3:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570715.2" sequenceAccession="NP_570715" sequenceVersion="2" change="p.Pro193fs">
            <Expression>NP_570715.2:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130804.3" sequenceAccession="NM_130804" sequenceVersion="3" change="c.578_579del">
            <Expression>NM_130804.3:c.578_579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570716.2" sequenceAccession="NP_570716" sequenceVersion="2" change="p.Pro193fs">
            <Expression>NP_570716.2:p.Pro193fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370263.2" sequenceAccession="NM_001370263" sequenceVersion="2" change="c.549+14_549+15del">
            <Expression>NM_001370263.2:c.549+14_549+15del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370262.2" sequenceAccession="NM_001370262" sequenceVersion="2" change="c.549+14_549+15del">
            <Expression>NM_001370262.2:c.549+14_549+15del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_509" sequenceAccession="LRG_509">
            <Expression>LRG_509:g.8313_8314del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658658066" DB="ClinGen" />
        <XRef Type="rs" ID="1555165756" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001370259.2(MEN1):c.563_564del (p.Pro188fs) AND Multiple endocrine neoplasia, type 1" Accession="RCV000529950" Version="7">
        <ClassifiedConditionList TraitSetID="5472">
          <ClassifiedCondition DB="MedGen" ID="C0025267">Multiple endocrine neoplasia, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001370259.2(MEN1):c.563_564del (p.Pro188fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002350189" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-26" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12112656</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15714081</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17853334</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28238068</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12656" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MEA I</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEN I</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Endocrine adenomatosis multiple</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEN 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wermer syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple endocrine neoplasia, type 1</ElementValue>
                <XRef ID="Multiple+endocrine+neoplasia+type+1/4955" DB="Genetic Alliance" />
                <XRef ID="30664006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MEN1</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Multiple endocrine neoplasia type 1 (MEN1) includes varying combinations of more than 20 endocrine and non-endocrine tumors. Endocrine tumors become evident either by overproduction of hormones by the tumor or by growth of the tumor itself. Parathyroid tumors are the most common MEN1-associated endocrinopathy; onset in 90% of individuals is between ages 20 and 25 years with hypercalcemia evident by age 50 years; hypercalcemia causes lethargy, depression, confusion, anorexia, constipation, nausea, vomiting, diuresis, dehydration, hypercalciuria, kidney stones, increased bone resorption/fracture risk, hypertension, and shortened QT interval. Pituitary tumors include prolactinoma (the most common), which manifests as oligomenorrhea/amenorrhea and galactorrhea in females and sexual dysfunction in males. Well-differentiated endocrine tumors of the gastro-entero-pancreatic (GEP) tract can manifest as Zollinger-Ellison syndrome (gastrinoma); hypoglycemia (insulinoma); hyperglycemia, anorexia, glossitis, anemia, diarrhea, venous thrombosis, and skin rash (glucagonoma); and watery diarrhea, hypokalemia, and achlorhydria syndrome (vasoactive intestinal peptide [VIP]-secreting tumor). Carcinoid tumors are non-hormone-secreting and can manifest as a large mass after age 50 years. Adrenocortical tumors can be associated with primary hypercortisolism or hyperaldosteronism. Non-endocrine tumors include facial angiofibromas, collagenomas, lipomas, meningiomas, ependymomas, and leiomyomas.</Attribute>
                <XRef ID="NBK1538" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3829" />
                <XRef ID="3829" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301710</ID>
                <ID Source="BookShelf">NBK1538</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="Brandi et al., 2001">
                <ID Source="PubMed">11739416</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="Thakker et al., 2012">
                <ID Source="PubMed">22723327</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <XRef ID="652" DB="Orphanet" />
              <XRef ID="C0025267" DB="MedGen" />
              <XRef ID="D018761" DB="MeSH" />
              <XRef ID="MONDO:0007540" DB="MONDO" />
              <XRef Type="MIM" ID="131100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1220307" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1585138|MedGen:C0025267" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000628089" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15714081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28238068</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112656</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17853334</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 457327). This variant is also known as codon 188 CCC&gt;C and c.563_564delGG, p.P188fs. This premature translational stop signal has been observed in individual(s) with multiple endocrine neoplasia type 1 (PMID: 15714081, 28238068). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro188Glnfs*7) in the MEN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MEN1 are known to be pathogenic (PMID: 12112656, 17853334).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64575453_64575454del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025267" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5135858" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8826959|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002652860" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28238068</ID>
          </Citation>
          <Comment>The c.563_564delCC pathogenic mutation, located in coding exon 2 of the MEN1 gene, results from a deletion of two nucleotides at nucleotide positions 563 to 564, causing a translational frameshift with a predicted alternate stop codon (p.P188Qfs*7). This variant has been observed in at least one individual with a personal and/or family history that is consistent with MEN1-related disease (Ambry internal data). This alteration was identified in a patient with a personal and family history of multiple endocrine neoplasia type 1 (Cuevas-Ocampo AK et al. Acta Neuropathol, 2017 04;133:661-663). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.563_564delCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1220307" TraitType="Disease" MappingType="XRef" MappingValue="C0025267" MappingRef="MedGen">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5135858" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

